Background: Spinal dysraphism represents a wide spectrum of congenital abnormalities of the spine. Myelomeningocele is considered the most common malformation and the most common we saw in our community, with its morbidity problems seen commonly in the postoperative period. ASQ-3TM Scores are the ages and stages questionnaire, third edition, and represent a tool to assess the development progress, especially in toddlers. Objectives: Evaluation of neurodevelopmental outcome among Sudanese toddlers with spinal dysraphism after surgical closure with or without a VP shunt using ASQ-3TM Scores. Methodology: This is a retrospective hospital-based study of 84 patients who underwent myelomeningocele repair at the National Center for Neurological Sciences (NCNS) during the period from 2017 up to 2019. Data were collected through a constructed questionnaire, including ASQ-3TM Scores. Data were processed and analyzed using the Statistical Package for Social Science (SPSS) computer program. Version 25. Results: 84 patients were included in this study; all patients were diagnosed with spinal dysraphism. Out of them, 51 (60.7%) were 2 years old, 33 (39.3%) were 3 years old, 45 (53.6%) were male, 45 (53.6%) of patients mothers attended ANC irregularly, and 54 (64.3%) their mothers didn’t receive folate supplements. 44 (52.3%) of patients underwent MMC repair only, while 40 (47.7%) underwent MMC repair and VP shunt. The commonest postoperative complication was infection, reported in 12 (14.3%) of patients, followed by VP shunt revision in 9 (10.7%) of patients. Neurological assessment showed that the majority of patients need further assessment with a professional, 57 (67.9%) of children don’t walk, run, or climb like other toddlers as their parent’s state; also, half of patients (42, 50%) had medical problems, and 27 (32.1%) of their parent’s state that they do not talk like other toddlers their age. There was a statistically significant association between post-operative complications and communication development, problem-solving development, and personal social development (P value = 0.05), and a statistically significant association was found between age at repair and neurological development (P value = 0.05). Conclusion: The majority of patients had motor deficiency (particularly gross motor) and poor personal and social skills. Age at repair and postoperative complications significantly influenced the neurological development.
References
[1]
Harwood-Nash, D.C. and McHugh, K. (1991) Diastematomyelia in 172 Children: The Impact of Modern Neuroradiology. Pediatric Neurosurgery, 16, 247-251. https://doi.org/10.1159/000120535
[2]
Morrow, J.D. and Kelsey, K. (1998) Folic Acid for Prevention of Neural Tube Defects: Pediatric Anticipatory Guidance. Journal of Pediatric Health Care, 12, 55-59. https://doi.org/10.1016/S0891-5245(98)90222-X
[3]
Oaks, W. and Gaskill, S. (1992) Symptomatic Chiari Malformations in Childhood. In: Park, T., Ed., Spinal Dysraphism, Blackwell Scientific Publications, Boston, 104-125.
Schorah, C. (2009) Dick Smithells, Folic Acid, and the Prevention of Neural Tube Defects. Birth Defects Research Part A: Clinical and Molecular Teratology, 85, 254-259. https://doi.org/10.1002/bdra.20544
[6]
Berry, R.J., Li, Z., Erickson, J.D., Li, S., Moore, C.A., Wang, H., Mulinare, J., Zhao, P., Wong, L.Y., Gindler, J., et al. (1999) Prevention of Neural-Tube Defects with Folic Acid in China. The New England Journal of Medicine, 341, 1485-1490. https://doi.org/10.1056/NEJM199911113412001
[7]
Czeizel, A.E., Dudás, I., Paput, L. and Bánhidy, F. (2011) Prevention of Neural-Tube Defects with Periconceptional Folic Acid, Methylfolate, or Multivitamins? Annals of Nutrition and Metabolism, 58, 263-271. https://doi.org/10.1159/000330776
[8]
Smithells, R.W., Sheppard, S., Schorah, C.J., Seller, M.J., Nevin, N.C., Harris, R., Read, A.P. and Fielding, D.W. (1981) Apparent Prevention of Neural Tube Defects by Periconceptional Vitamin Supplementation. Archives of Disease in Childhood, 56, 911-918. https://doi.org/10.1136/adc.56.12.911
[9]
Wals, P.D., Tairou, F., Allen, M.I.V., Uh, S.H., Lowry, R.B., Sibbald, B., Evans, J.A., den Hof, M.C.V., Zimmer, P., Crowley, M., et al. (2007) Reduction in Neural-Tube Defects after Folic Acid Fortification in Canada. The New England Journal of Medicine, 357, 135-142. https://doi.org/10.1056/NEJMoa067103
[10]
Williams, L.J., Mai, C.T., Edmonds, L.D., Shaw, G.M., Kirby, R.S., Hobbs, C.A., Sever, L.E., Miller, L.A., Meaney, F.J. and Levitt, M. (2002) Prevalence of Spina Bifida and Anencephaly during the Transition to Mandatory Folic Acid Fortification in the United States. Teratology, 66, 33-39. https://doi.org/10.1002/tera.10060
[11]
Food and Drug Administration (1996) Food Standards: Amendment of Standards of Identity for Enriched Grain Products to Require Addition of Folic Acid. https://www.govinfo.gov/app/details/FR-1996-08-05/96-19803
[12]
Morris, J.K., Addor, M.C., Ballardini, E., Barisic, I., Barrachina-Bonet, L., Braz, P., Cavero-Carbonell, C., Hond, E.D., Garne, E., Gatt, M., et al. (2021) Prevention of Neural Tube Defects in Europe: A Public Health Failure. Frontiers in Pediatrics, 9, Article 647038. https://doi.org/10.3389/fped.2021.647038
[13]
Bauer, S.B., Labib, K.B., Dieppa, R.A. and Retik, A.B. (1977) Urodynamic Evaluation of Boy with Myelodysplasia and Incontinence. Urology, 10, 354-362. https://doi.org/10.1016/0090-4295(77)90168-6
[14]
Tubbs, R.S. and Oakes, W.J. (2013) The Chiari Malformations. Springer, New York. https://doi.org/10.1007/978-1-4614-6369-6
[15]
Akalan, N. (2011) Myelomeningocele (Open Spina Bifida)—Surgical Management. Advances and Technical Standards in Neurosurgery, 37, 113-141. https://doi.org/10.1007/978-3-7091-0673-0_5
[16]
Davis, B.E., Daly, C.M., Shurtleff, D.B., Duguay, S., Seidel, K., Loeser, J.D., et al. (2005) Long-Term Survival of Individuals with Myelomeningocele. Pediatric Neurosurgery, 41, 186-191. https://doi.org/10.1159/000086559
[17]
McDowell, M.M., Blatt, J.E., Deibert, C.P., Zwagerman, N.T., Tempel, Z.J. and Greene, S. (2018) Predictors of Mortality in Children with Myelomeningocele and Symptomatic Chiari Type II Malformation. Journal of Neurosurgery: Pediatrics, 21, 587-596. https://doi.org/10.3171/2018.1.PEDS17496
[18]
Waqar Aziz, R., Muhammad Ali, B. and Hussnain, A. (2015) Frequency of Hydrocephalus in Myelomeningocele Patients in a Tertiary Care Hospital. Journal of Sheikh Zayed Medical College, 6, 882-884.
[19]
Tuli, S., Tuli, J., Drake, J. and Spears, J. (2004) Predictors of Death in Pediatric Patients Requiring Cerebrospinal Fluid Shunts. Journal of Neurosurgery, 100, 442-446. https://doi.org/10.3171/ped.2004.100.5.0442
[20]
Ganesh, D., Sagayaraj, B.M., Barua, R.K., Sharma, N. and Ranga, U. (2014) Arnold Chiari Malformation with Spina Bifida: A Lost Opportunity of Folic Acid Supplementation. Journal of Clinical and Diagnostic Research, 8, OD01-OD03. https://doi.org/10.7860/JCDR/2014/11242.5335
[21]
Gursoy, K., Ustun, G.G., Akduman, B., Ozpostaci, M.O., Kankaya, Y. and Kocer, U. (2020) Analysis of Wound Complications of Patients with Meningomyelocele. Turkish Journal of Plastic Surgery, 28, 19-24.
[22]
Demir, N., Peker, E., Gülşen, İ., Ağengin, K. and Tuncer, O. (2015) Factors Affecting Infection Development after Meningomyelocele Repair in Newborns and the Efficacy of Antibiotic Prophylaxis. Child’s Nervous System, 31, 1355-1359. https://doi.org/10.1007/s00381-015-2701-y
[23]
Inversetti, A., Van der Veeken, L., Thompson, D., Jansen, K., Van Calenbergh, F., Joyeux, L., Bosteels, J. and Deprest, J. (2019) Neurodevelopmental Outcome of Children with Spina Bifida Aperta Repaired Prenatally vs Postnatally: Systematic Review and Meta-Analysis. Ultrasound in Obstetrics & Gynecology, 53, 293-301. https://doi.org/10.1002/uog.20188
[24]
Verhoef, M., Barf, H.A., Post, M.W.M., van Asbeck, F.W.A., Gooskens, R.H.J.M. and Prevo, A.J.H. (2006) Functional Independence among Young Adults with Spina Bifida, in Relation to Hydrocephalus and Level of the Lesion. Developmental Medicine & Child Neurology, 48, 114-119. https://doi.org/10.1017/S0012162206000259
[25]
Tarcan, T., Onol, F.F., Ilker, Y., Alpay, H., Simşek, F. and Ozek, M. (2006) The Timing of Primary Neurosurgical Repair Significantly Affects Neurogenic Bladder Prognosis in Children with Myelomeningocele. Journal of Urology, 176, 1161-1165. https://doi.org/10.1016/j.juro.2006.04.042
Nagaraj, U.D., Bierbrauer, K.S., Zhang, B., Peiro, J.L. and Kline-Fath, B.M. (2017) Hindbrain Herniation in Chiari II Malformation on Fetal and Postnatal MRI. American Journal of Neuroradiology, 38, 1031-1036. https://doi.org/10.3174/ajnr.A5116
[28]
Jacobs, R., Northam, E. and Anderson, V. (2001) Cognitive Outcome in Children with Myelomeningocele and Perinatal Hydrocephalus: A Longitudinal Perspective. Journal of Developmental and Physical Disabilities, 13, 389-405. https://doi.org/10.1023/A:1012289513829
[29]
Stevenson, K.L. (2004) Chiari Type II Malformation: Past, Present, and Future. Neurosurgical Focus, 16, 1-7. https://doi.org/10.3171/foc.2004.16.2.6
[30]
Kakebeeke, T.H., Knaier, E., Kochli, S., et al. (2016) Comparison € between the Movement ABC-2 and the Zurich Neuromotor Assessment in Preschool Children. Perceptual and Motor Skills, 123, 687-701. https://doi.org/10.1177/0031512516664991
